Cargando…

Therapy-related myeloid neoplasms: clinical perspectives

Therapy-related myeloid neoplasms (t-MNs) are a complication of cytotoxic treatment for primary tumors and autoimmune diseases. t-MNs result from a complex interaction between individual predisposition and exposition to toxic agents. Some different biological and clinical characteristics can be reco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fianchi, Luana, Criscuolo, Marianna, Fabiani, Emiliano, Falconi, Giulia, Maraglino, Alessio Maria Edoardo, Voso, Maria Teresa, Pagano, Livio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149829/ https://www.ncbi.nlm.nih.gov/pubmed/30271175 http://dx.doi.org/10.2147/OTT.S101333

Ejemplares similares

Similarities and Differences Between Therapy-Related and Elderly Acute Myeloid Leukemia
por: D’Alò, Francesco, et al.
Publicado: (2011)

Clonal evolution in therapy-related neoplasms
por: Fabiani, Emiliano, et al.
Publicado: (2017)

Mastocytosis: One Word for Different Diseases
por: Criscuolo, Marianna, et al.
Publicado: (2018)

Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years’ Experience
por: Fianchi, Luana, et al.
Publicado: (2021)

Outcome of therapy-related myeloid neoplasms treated with azacitidine
por: Fianchi, Luana, et al.
Publicado: (2012)

From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression
por: Gurnari, Carmelo, et al.
Publicado: (2021)

Therapy-Related Myeloid Neoplasms: Predisposition and Clonal Evolution
por: Fabiani, Emiliano, et al.
Publicado: (2023)

Fanconi anemia gene variants in therapy-related myeloid neoplasms
por: Voso, M T, et al.
Publicado: (2015)

Incidence of Acute Myeloid Leukemia after Breast Cancer
por: Valentini, Caterina Giovanna, et al.
Publicado: (2011)

The Role of Forkhead Box Proteins in Acute Myeloid Leukemia
por: Gurnari, Carmelo, et al.
Publicado: (2019)

Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis
por: Falconi, Giulia, et al.
Publicado: (2022)

Risk of infection in elderly patients with AML and MDS treated with hypomethylating agents
por: Livio, Pagano, et al.
Publicado: (2018)

5-Azacytidine in Chronic Myelomonocytic Leukemia: Case Report and Review of Literature.
por: Greco, M., et al.
Publicado: (2011)

Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes
por: Falconi, Giulia, et al.
Publicado: (2018)

Disseminated Geosmithia argillacea Infection in a Patient with Ph-Positive Acute Lymphoblastic Leukemia. Case Report and Literature Review
por: Giordano, Antonio, et al.
Publicado: (2021)

Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis
por: Guarnera, Luca, et al.
Publicado: (2022)

De Novo and Therapy-Related Myelodysplastic Syndromes: Analogies and Differences
por: Leone, Giuseppe, et al.
Publicado: (2022)

PB2465: ALLOGENEIC HSCT OUTCOMES IN SIX PATIENTS WITH THERAPY RELATED MYELOID NEOPLASMS WITH A HISTORY OF OVARIAN CANCER TREATED WITH CHEMOTERAPY AND PARP INHIBITORS
por: Maria Edoardo Maraglino, Alessio, et al.
Publicado: (2023)

Clinical Aspects and Therapy of Sporadic Burkitt Lymphoma
por: Pagano, Livio, et al.
Publicado: (2009)

Infectious complications during monoclonal antibodies treatments and cell therapies in Acute Lymphoblastic Leukemia
por: Quattrone, Martina, et al.
Publicado: (2023)

Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes
por: Cristiano, Antonio, et al.
Publicado: (2023)

Mutational profile of ZBTB16‐RARA‐positive acute myeloid leukemia
por: Fabiani, Emiliano, et al.
Publicado: (2021)

Bone Marrow Microenvironment Involvement in t-MN: Focus on Mesenchymal Stem Cells
por: Falconi, Giulia, et al.
Publicado: (2023)

New Treatments for Myelodysplastic Syndromes
por: D’Alò, Francesco, et al.
Publicado: (2010)

Treatment of Low-Blast Count AML using Hypomethylating Agents
por: De Bellis, Eleonora, et al.
Publicado: (2017)

The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19
por: Cristiano, Antonio, et al.
Publicado: (2022)

Therapy-related myeloid neoplasms in children and adolescents
por: Cho, Hee Won, et al.
Publicado: (2016)

Isolated Orbital Myeloid Sarcoma as a Therapy-related Myeloid Neoplasm
por: Ishiguro, Kazuya, et al.
Publicado: (2018)

Therapy-related Myeloid Neoplasms: Considerations for Patients’ Clinical Evaluation
por: Palmieri, Raffaele, et al.
Publicado: (2023)

Genetic Pathways Leading to Therapy-Related Myeloid Neoplasms
por: Stoddart, Angela, et al.
Publicado: (2011)

Intrasinusoidal proerythroblast infiltration in therapy related myeloid neoplasm
por: Li, Jian, et al.
Publicado: (2023)

The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia
por: Fabiani, Emiliano, et al.
Publicado: (2017)

Therapy-related myeloid neoplasms as a concerning complication in acute promyelocytic leukemia
por: Vicente-Ayuso, María del Carmen, et al.
Publicado: (2017)

Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes
por: Faraoni, Isabella, et al.
Publicado: (2019)

Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
por: Scardocci, A, et al.
Publicado: (2006)

Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting
por: Attardi, Enrico, et al.
Publicado: (2023)

Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms
por: Shah, Mithun Vinod, et al.
Publicado: (2022)

Therapy-Related Myeloid Neoplasm in Non-Hodgkin Lymphoma Survivors
por: Bari, Alessia, et al.
Publicado: (2011)

Therapy-Related Myeloid Neoplasms in Patients Treated for Hodgkin Lymphoma
por: Eichenauer, D.A., et al.
Publicado: (2011)

The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
por: Schwartz, Jason R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_de1ptgpptnqafepslpc4hlqrs2